ストックスクリーナーアプリを入手
47.17
1.88%
0.87
前日終値:
$46.30
開ける：
$46.81
24時間の取引高:
1.77M
Relative Volume:
1.04
時価総額：
$2.53B
収益：
-
当期純損益:
$-38.99M
株価収益率:
-15.74
EPS:
-2.9966
ネットキャッシュフロー:
$-24.94M
1週間 パフォーマンス:
-1.01%
1か月 パフォーマンス:
-1.96%
6か月 パフォーマンス:
-45.28%
1年 パフォーマンス:
+3.19%
1日の値動き範囲:
$46.01
$47.98
1週間の範囲:
$45.06
$48.38
52週間の値動き範囲:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
名前
Soleno Therapeutics Inc
セクター
電話
650-213-8444
住所
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
47.17 | 2.49B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-10-07 | 開始されました | Goldman | Buy |
| 2025-08-20 | 開始されました | Wells Fargo | Overweight |
| 2025-06-23 | 開始されました | TD Cowen | Buy |
| 2025-03-05 | 再開されました | Stifel | Buy |
| 2024-12-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2024-12-02 | 繰り返されました | Stifel | Buy |
| 2024-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-05 | 開始されました | Piper Sandler | Overweight |
| 2024-01-23 | 開始されました | Stifel | Buy |
| 2023-11-21 | 再開されました | Guggenheim | Buy |
| 2020-09-29 | 開始されました | Guggenheim | Buy |
| 2020-01-10 | 開始されました | Craig Hallum | Buy |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Soleno Therapeutics Inc (SLNO) 最新ニュース
Soleno Therapeutics, Inc. $SLNO Stake Cut by Voya Investment Management LLC - MarketBeat
Understanding Momentum Shifts in (SLNO) - Stock Traders Daily
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Risk Hedge: Why analysts recommend Soleno Therapeutics Inc 6XC stock2025 Trading Volume Trends & Community Consensus Trade Alerts - moha.gov.vn
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) - Business Wire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Shareholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - FinancialContent
Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips - ts2.tech
2025-12-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics, Inc. $SLNO Stake Lessened by Harbor Capital Advisors Inc. - MarketBeat
Market Sentiment Around Loss-Making Soleno Therapeutics, Inc. (NASDAQ:SLNO) - 富途牛牛
Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN
Piper Sandler Reaffirms Overweight Rating on Soleno (SLNO) Driven by Strong VYKAT XR Prospects - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-12-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Learn More About the Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics Earnings Notes - Trefis
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Soleno Therapeutics Inc. stock affected by interest rate hikesMarket Sentiment Report & Free High Margin Investment Plays - bollywoodhelpline.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2025-12-24 | Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Stockholders to Inquire about Securities Investigation | NDAQ:SLNO | Press Release - Stockhouse
Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire
Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛
Fed Meeting: What momentum indicators show for Soleno Therapeutics Inc. stock2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Will Soleno Therapeutics Inc. stock see insider buyingQuarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Why Soleno Therapeutics Inc. stock could rally in 2025Dollar Strength & Weekly Top Stock Performers List - Улправда
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire
Can Soleno Therapeutics Inc. stock hit record highs again2025 Year in Review & Fast Gaining Stock Reports - DonanımHaber
How Soleno Therapeutics Inc. stock performs in weak economyPortfolio Risk Report & Low Drawdown Momentum Trade Ideas - Улправда
Rate Hike: What momentum indicators show for Soleno Therapeutics Inc. stockJuly 2025 Technicals & Community Verified Trade Signals - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out - ACCESS Newswire
VP Huang Surrenders 812 Of Soleno Therapeutics Inc [SLNO] - TradingView — Track All Markets
VP Yen Surrenders 904 Of Soleno Therapeutics Inc [SLNO] - TradingView — Track All Markets
CFO Mackaness Surrenders 2,013 Of Soleno Therapeutics Inc [SLNO] - TradingView — Track All Markets
Soleno Therapeutics (SLNO) CEO discloses 100,000-share gift and updated holdings - Stock Titan
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - Morningstar
Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals - Sahm
Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance
How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story - Yahoo Finance
34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC - MarketBeat
Soleno Therapeutics Gains Momentum Following Wolfe Research Favorable Rating - timothysykes.com
Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat
Soleno Therapeutics Stock Poised for Growth as Wolfe Research Issues Positive Rating - StocksToTrade
Soleno Therapeutics Rises as Wolfe Research Gives Positive Outlook - timothysykes.com
Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Will Vykat XR Approval and Board Shift Reshape Soleno Therapeutics' (SLNO) Investment Narrative? - Sahm
Soleno Therapeutics Inc (SLNO) 財務データ
収益
当期純利益
現金流量
EPS
Soleno Therapeutics Inc (SLNO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hirano Patricia C | SEE REMARKS |
Jul 01 '25 |
Sale |
82.76 |
3,830 |
316,971 |
13,206 |
0.57%
大文字化:
|
ボリューム (24 時間):